UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039495
Receipt number R000044971
Scientific Title Retrospective clinical evaluation of chorioretinal disease
Date of disclosure of the study information 2020/02/16
Last modified on 2023/08/19 10:34:04

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Retrospective clinical evaluation of chorioretinal disease

Acronym

Retrospective clinical evaluation of chorioretinal disease

Scientific Title

Retrospective clinical evaluation of chorioretinal disease

Scientific Title:Acronym

Retrospective clinical evaluation of chorioretinal disease

Region

Japan


Condition

Condition

chorioretinal disease

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To retrospectively evaluate the associated clinical factors of chorioretinal disease for visual function

Basic objectives2

Others

Basic objectives -Others

To retrospectively evaluate the association of clinical factors and visual function in chorioretinal disease

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

visual acuity. visual field, color vision

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The patients with chorioretinal disorders who underwent examination or treatment at department of Ophthalmology in Tokyo Medical University, Ibaraki Medical Center.

Key exclusion criteria

The patients who refuse to participate this study.

Target sample size

7500


Research contact person

Name of lead principal investigator

1st name Masahiro
Middle name
Last name Miura

Organization

Tokyo Medical University Ibaraki Medical Center

Division name

Dept. of Ophthalmology

Zip code

3000395

Address

3-20-1 Chuo, Ami, Inashiki, Ibaraki

TEL

029-8871161

Email

m-miura@tokyo-med.ac.jp


Public contact

Name of contact person

1st name Masahiro
Middle name
Last name Miura

Organization

Tokyo Medical University Ibaraki Medical Center

Division name

Dept. of Ophthalmology

Zip code

3000395

Address

3-20-1 Chuo, Ami, Inashiki, Ibaraki

TEL

029-8871161

Homepage URL

http://www.tokyo-med.ac.jp/iba-eye/IRB_list.html

Email

m-miura@tokyo-med.ac.jp


Sponsor or person

Institute

Dept. of Ophthalmology,Tokyo Medical University Ibaraki Medical Center

Institute

Department

Personal name



Funding Source

Organization

Tokyo Medical University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board, Tokyo Medical University

Address

6-1-1 Nishi-shinjuku, Shinjuku, Tokyo 1600023 Japan

Tel

03-3351-6141

Email

irb@tokyo-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 02 Month 16 Day


Related information

URL releasing protocol

http://www.tokyo-med.ac.jp/iba-eye/IRB_list.html

Publication of results

Partially published


Result

URL related to results and publications

https://www.dovepress.com/modified-low-power-mode-laser-for-the-treatment-of-central-serous-chor-pee

Number of participants that the trial has enrolled

4

Results

Treatment efficacy of low power mode laser for central serous chorioretinopathy

Results date posted

2021 Year 02 Month 16 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results

2020 Year 11 Month 30 Day

Baseline Characteristics

central serous chorioretinopathy

Participant flow


Adverse events

None

Outcome measures

OCT finding

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2020 Year 01 Month 24 Day

Date of IRB

2020 Year 01 Month 24 Day

Anticipated trial start date

2020 Year 01 Month 24 Day

Last follow-up date

2028 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Retrospective, non-invasive, observational study


Management information

Registered date

2020 Year 02 Month 16 Day

Last modified on

2023 Year 08 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044971


Research Plan
Registered date File name
2021/08/18 研究実施計画書_網膜後ろ向き2020017修正承認.docx

Research case data specifications
Registered date File name

Research case data
Registered date File name